COVID-19 updates, including vaccine information, for our patients and visitors Learn More

Menu
Search

Internationally Renowned UCSD Physician-Researcher Chosen as Distinguished Scientist by American Heart Association

 

December 03, 2010  |  

Michael H.Criqui, MD, MPH, FAHA, professor and chief of the Division of Preventive Medicine in the Department of Family and Preventive Medicine at the University of California, San Diego was honored as a Distinguished Scientist by the American Heart Association (AHA) at this year’s AHA Scientific Sessions in Chicago, Illinois.  This is the highest honor given by the AHA.

Michael Criqui

Dr. Michael Criqui was named 1 of 5 AHA Distinguished Scientists for 2010

In 2003, the American Heart Association created a Distinguished Scientist designation to honor AHA/ASA members who have made extraordinary contributions to cardiovascular and stroke research.   This title recognizes seminal research work that has importantly advanced the understanding and management of cardiovascular disease or stroke.

Criqui is one of five honorees this year to join the ranks of 65 other preeminent researchers and scientists.  He is an active and productive investigator in cardiovascular epidemiology and preventive cardiology, and has made seminal contributions in the fields of peripheral arterial disease, subclinical atherosclerosis and peripheral venous disease.  Criqui has published over 385 manuscripts and book chapters and has been an invited lecturer at numerous national and international meetings.

# # #

Media Contact: Kim Edwards, 619-543-6163, kedwards@ucsd.edu


Related Specialties



Media Contact

Share This Article


Related News

7/23/2021
Senate President Pro Tempore Toni Atkins visited UC San Diego Medical Center today to recognize a $30 million allocation in the 2021-2022 California state budget that will support the redevelopment of ...
7/16/2021
Researchers at UC San Diego School of Medicine and Rady Children’s Institute for Genomic Medicine have produced a stem cell model that demonstrates a potential route of entry of SARS-CoV-2, the virus ...
7/15/2021
Using anonymized medical records from a national registry, UC San Diego researchers confirm earlier findings that statins may substantially minimize adverse outcomes from SARS-CoV-2 infection.
7/12/2021
UC San Diego researchers discovered that immunotoxins targeting the protein mesothelin prevent liver cells from producing collagen, a precursor to fibrosis and cirrhosis, in mouse models of human dise ...



Follow Us